Shares of Hutchison China MediTech Limited (LON:HCM) hit a new 52-week high on Wednesday . The company traded as high as GBX 524 ($6.85) and last traded at GBX 520 ($6.79), with a volume of 125281 shares trading hands. The stock had previously closed at GBX 521 ($6.81).
Separately, Barclays reissued an “equal weight” rating on shares of Hutchison China MediTech in a report on Wednesday, July 15th.
The company has a debt-to-equity ratio of 9.07, a current ratio of 3.14 and a quick ratio of 3.01. The firm has a 50 day simple moving average of GBX 476.70 and a 200-day simple moving average of GBX 386.14. The company has a market cap of $3.70 billion and a price-to-earnings ratio of -31.71.
Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for cancer and immunological diseases in the People's Republic of China and Hong Kong. It operates through Innovation Platform and Commercial Platform segments.
Further Reading: What is the S&P/ASX 200 Index?
Receive News & Ratings for Hutchison China MediTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hutchison China MediTech and related companies with MarketBeat.com's FREE daily email newsletter.